Tandem Diabetes Care, Inc. (TNDM)

NASDAQ: TNDM · IEX Real-Time Price · USD

39.15

-0.30 (-0.76%)

At close: Jul 2, 2024, 4:00 PM

38.69

-0.46 (-1.17%)

After-hours: Jul 2, 2024, 7:30 PM EDT

Tandem Diabetes Care Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2011
Net Income	-222.61	-94.59	15.57	-34.38	-24.75	Upgrade
Depreciation & Amortization	15.72	14.33	13.85	10.45	6.07	Upgrade
Share-Based Compensation	88.08	84.92	60.75	58.43	58.07	Upgrade
Other Operating Activities	87.01	45.81	21.2	-9.83	2.52	Upgrade
Operating Cash Flow	-31.81	50.46	111.36	24.67	41.91	Upgrade
Operating Cash Flow Growth	-	-54.68%	351.41%	-41.13%	-	Upgrade
Capital Expenditures	-26.8	-34.1	-14.18	-27.41	-19.54	Upgrade
Acquisitions	-94.3	-34.58	-9.33	-4.89	0	Upgrade
Change in Investments	35.36	101.84	-163.37	-263.76	-37.41	Upgrade
Investing Cash Flow	-85.74	33.17	-186.88	-296.06	-56.96	Upgrade
Share Issuance / Repurchase	4.18	17.55	51.93	69.82	24.21	Upgrade
Debt Issued / Paid	0	0	0	244.62	0	Upgrade
Other Financing Activities	-0.07	-0.68	-	-	-	Upgrade
Financing Cash Flow	4.11	16.88	51.93	314.44	24.21	Upgrade
Exchange Rate Effect	-0.21	0.83	0.15	0.39	0.19	Upgrade
Net Cash Flow	-113.65	101.34	-23.43	43.44	9.35	Upgrade
Free Cash Flow	-58.61	16.37	97.18	-2.74	22.37	Upgrade
Free Cash Flow Growth	-	-83.16%	-	-	-	Upgrade
Free Cash Flow Margin	-7.84%	2.04%	13.83%	-0.55%	6.17%	Upgrade
Free Cash Flow Per Share	-0.90	0.26	1.54	-0.04	0.38	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).